Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Ganmaoling tablet
- Development stage
- Unknown
- Lead developer
- Hainan Linheng Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Compound Ganmaoling tablet (复方感冒灵片) is an approved compound traditional Chinese and Western medicine widely used in China for the treatment of the common cold and influenza, particularly wind-heat common cold. It is a fixed-dose combination containing both herbal extracts—including Lonicerae Japonicae Flos (honeysuckle), Viticis Negundo Folium, Chrysanthemi Indici Flos (wild chrysanthemum), Evodiae Lepta Folium et Ramulus, Baphicacanthis Cuspidati Rhizoma et Radix, and Ilicis Asprellae Radix—and Western chemical active ingredients, namely acetaminophen, chlorpheniramine maleate, and caffeine. The herbal components provide heat-clearing, detoxifying, and exterior-relieving effects, while acetaminophen acts as an antipyretic and analgesic, chlorpheniramine maleate serves as an antihistamine to relieve nasal symptoms, and caffeine acts as a central nervous system stimulant to counteract drowsiness. It is manufactured and marketed by several pharmaceutical companies in China, including Hainan Linheng Pharmaceutical under the brand name Kuaisuda.
- Brand names
- GuanHeHaoLiKangKuaisudaShuangyi
- Other names
- Fufang Ganmaoling Pian复方感冒灵片
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Compound Ganmaoling tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Ganmaoling tablet.